Your browser doesn't support javascript.
loading
Rilotumumab Resistance Acquired by Intracrine Hepatocyte Growth Factor Signaling.
Cecchi, Fabiola; Rex, Karen; Schmidt, Joanna; Vocke, Cathy D; Lee, Young H; Burkett, Sandra; Baker, Daniel; Damore, Michael A; Coxon, Angela; Burgess, Teresa L; Bottaro, Donald P.
Afiliação
  • Cecchi F; Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
  • Rex K; Amgen, Inc., Thousand Oaks, CA 91320, USA.
  • Schmidt J; Amgen, Inc., Thousand Oaks, CA 91320, USA.
  • Vocke CD; Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
  • Lee YH; Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
  • Burkett S; Molecular Cytogenetics Core Facility, Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD 21702, USA.
  • Baker D; Amgen, Inc., Thousand Oaks, CA 91320, USA.
  • Damore MA; Amgen, Inc., Thousand Oaks, CA 91320, USA.
  • Coxon A; Amgen, Inc., Thousand Oaks, CA 91320, USA.
  • Burgess TL; Amgen, Inc., Thousand Oaks, CA 91320, USA.
  • Bottaro DP; Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Cancers (Basel) ; 15(2)2023 Jan 11.
Article em En | MEDLINE | ID: mdl-36672409

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Screening_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Screening_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article